About 200 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Dermatological Treatment
  • Immunology
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Students are also demonstrated the examination of gastrointestinal endoscopy.

  • Healthcare
  • Managed Care
  • Medical Education
  • World
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Dermatological Treatment
  • Immunology
  • Managed Care
  • World
  • Forecast
  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUES FOR CIMZIA ($BN), 2006-2022
  • IMMUNOLOGY, GLOBAL, ANNUAL REVENUE FORECAST FOR UPADACITINIB ($M), 2015-2022

Gastrointestinal Cancer Research; ##(##): ##-## Mayo Clinic (2014).

  • Dermatological Treatment
  • Immunology
  • Managed Care
  • World
  • Janssen Biotech, Inc.
  • Establish ed
  • 4.2 Key Therapy Areas by Indication

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and...

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Market Size

Report Title Published Date ##.

  • Immunology
  • Managed Care
  • North America
  • United States
  • Horizon Discovery

Scope of Business: ##.

  • Dermatological Treatment
  • Immunology
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

We are one of the nation' s Top ## health systems.

  • Immunology
  • Managed Care
  • United States
  • Supply
  • GlobalData's company

Scope of Business: ##.

  • Dermatological Treatment
  • Immunology
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Immunology
  • Managed Care
  • Allergan plc
  • Galderma S.A.
  • Pipeline Landscape Assessment

Excluded from this report are Crohn' s disease and ulcerative colitis, as they fall under the gastrointestinal disorders therapy area.

  • Dermatological Treatment
  • Immunology
  • World
  • Market Size
  • Novartis AG

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • Central Nervous System
  • Research Contact: info@globaldata.com

Besides, one PE deal worth USD##m was recorded in Q## 2017.

  • Immunology
  • Neurology
  • World
  • Company
  • Deals & Alliance
  • Research Contact: info@globaldata.com

Besides, one VC deal worth USD##. ##m was reported in Q## 2016.

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF ACUTE GVHD, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF CHRONIC GVHD, 2018

Ulcerative colitis and CD are similar in that they are chronic, inflammatory gastrointestinal diseases, but they can be differentiated from one another by the location of the affected area of the gastrointestinal tract, and by the differences in histological features of th

  • Autoimmune Disease
  • Dermatological Treatment
  • Healthcare
  • Immunology
  • Managed Care
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Australia
  • United States
  • Company Financials
  • Fresenius Group

In the AR## arm, ##. ##% of patients discontinued due to investigator-reported adverse events, including ##. ##% due to gastrointestinal adverse events and ##. ##% due to systemic allergic hypersensitivity reactions.

  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Clinic
  • Dermatological Treatment
  • Immunology
  • Managed Care
  • GlobalData's company

## ## ## United States ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## France ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Baxter International Inc.

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Baxter International Inc.

The prominent features of this report are - ##.

  • Dermatological Treatment
  • Drug Discovery And Development
  • Immunology
  • World
  • Product Initiative

Company type Partner ##: enGene, Inc.

  • Healthcare
  • Immunology
  • Managed Care
  • Pharmaceutical
  • Therapy

One unit is one oximeter sensor.

  • Managed Care
  • Respiratory Monitoring
  • United States
  • Company
  • GlobalData's company

Company type Partner ##: enGene, Inc.

  • Healthcare
  • Immunology
  • Managed Care
  • Pharmaceutical
  • Therapy

PARTNER ##: JAPAN TOBACCO INC.

  • Dermatological Treatment
  • Diabetes
  • Immunology
  • Managed Care
  • Merck & Co., Inc.

## ## ## ## ## ## ## Danone SA United Pharmaceuticals SAS ## ## ## ## ## ## ## ## ## ## ## ## ## ## DBV Technologies SA ## ## ## ## ## ## ## Danone Research BV ## ## ## ## ## ## ## Biosearch Life ## ## ## ## ## ## ## FrieslandCampina Innovation Interna

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cytokine
  • Dermatological Treatment
  • Immunology
  • Japan
  • World

PARTNER ##: JAPAN TOBACCO INC.

  • Dermatological Treatment
  • Diabetes
  • Immunology
  • Managed Care
  • Merck & Co., Inc.